Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity
Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company specializing in developing and commercializing products to treat rare diseases with unmet medical needs. The Company's primary focus is on its Specialized BioTherapeutics business segment, which is responsible for the development of HyBryteâ„¢, a novel photodynamic therapy that uses safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). The Company has successfully completed a Phase 3 study for HyBryteâ„¢ and is now negotiating a confirmatory Phase 3 pivotal study design with the US Food & Drug Administration, while also evaluating/pursuing potential HyBryteâ„¢ marketing approval ex-U.S. with the successfully completed Phase 3 study. Visit SNGXinfo.com to learn more.
-
1:20:52
Michael Franzese
21 hours agoMichael Franzese LIVE! | Democrat Failures & The Upcoming Election | Ep. 8
8.2K13 -
8:36
Adam Does Movies
17 hours ago $5.34 earnedThe Bikeriders Movie Review - It's Not What You Think
53.6K13 -
LIVE
LFA TV
6 hours agoTRUMP PHILADELPHIA RALLY LIVE @1PM EST
1,531 watching -
59:26
Trumpet Daily
1 day ago $3.29 earnedHamas Has a Friend in the Biden Administration - Trumpet Daily | June 21, 2024
11.5K28 -
1:13:51
Edge of Wonder
22 hours agoCIA Remote Viewed Jupiter, New Spider-Man Mandela Effect & Weird News
47.8K24 -
1:41:29
2 MIKES LIVE
21 hours ago2 MIKES LIVE #81 OPEN MIKE FRIDAY!
26.1K4 -
1:10:19
Wendy Bell Radio
5 hours agoPet Talk With The Pet Doc (CBD and Mushroooms for Pets)
22K13 -
42:43
The Why Files
3 days agoProof of Life After Death: Hope and a Warning From The Other Side
60.4K142 -
1:40:35
Flyover Conservatives
15 hours agoShocking Facts about the Largest Structure EVER Built by Man - Conspiracy Conversations (EP #40) with David Whited - Timothy Schwab
43.6K27 -
10:03
JoBlo Horror Originals
1 day agoThe Running Man: What Happened To This Adaptation?
29.2K24